Every Form 4 that IBEX Limited (IBEX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IBEX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IBEX filings page.
Jones John William reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director John William Jones received an equity award of 2,250 common shares through restricted stock units. The RSUs carry a right to one common share each at no cash cost. The award vests 25% on July 1, 2026 and 25% annually for three additional years, contingent on his continued service. Following this grant, his direct ownership totals 15,244 common shares.
IBEX Ltd director Zhuang Mingzhe acquired 2,083 common shares through a stock award. The Form 4 shows a grant of restricted stock units (RSUs) at a price of $0.00 per share, increasing his direct holdings to 7,083 common shares.
The RSUs vest over four years. Twenty‑five percent vest on July 1, 2026, with an additional 25% vesting on each of the next three anniversaries, as long as he remains in continuous service on each vesting date.
Ballou-Aares Daniella reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director Daniella Ballou-Aares received an equity award of 2,083 common shares in the form of restricted stock units. The RSUs were granted at no cash cost and increase her direct holdings to 17,143 common shares. Twenty-five percent of the RSUs vest on July 1, 2026, with the remaining 75% vesting in equal annual installments over the following three years, contingent on her continued service.
McGinnis Patrick reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director Patrick McGinnis reported an equity award of 2,083 common shares in the form of restricted stock units (RSUs). The RSUs were granted at no cash price and increase his directly owned common shares to 6,863 after the transaction.
The footnote explains that each RSU represents a contingent right to receive one common share. Twenty-five percent of the RSUs vest on July 1, 2026, with the remaining 75% vesting in equal annual installments over the following three years, assuming he remains in continuous service on each vesting date.
Beck Fiona Elizabeth reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director Fiona Elizabeth Beck reported an equity award. She was granted 2,083 restricted stock units (RSUs), each representing a right to receive one common share at no cost. 25% of the RSUs vest on July 1, 2026, with the remaining 75% vesting in equal annual installments over the following three years, contingent on continued service. After this grant, her reported direct holdings total 13,583 common shares.
Batungbacal Karen reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director Karen Batungbacal reported an equity award of 2,083 common-share-based restricted stock units (RSUs). Each RSU represents the right to receive one common share. According to the vesting schedule, 25% of the RSUs vest on July 1, 2026, with an additional 25% vesting on each of the next three yearly anniversaries, as long as she remains in continuous service with the company.
Keen Shuja reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director Keen Shuja reported an equity award of 5,000 restricted stock units (RSUs). These RSUs give a contingent right to receive one common share for each unit. According to the grant terms, 25% of the RSUs vest on March 2, 2027, with an additional 25% vesting on the same date in each of the following three years, as long as Shuja remains in continuous service on each vesting date. The award was recorded at a price of $0.00 per share, reflecting that this is a compensation grant rather than an open-market purchase.
Dechant Robert Thomas reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd reported that Chief Executive Officer Robert Thomas Dechant received an award of 18,000 Common Share–settled restricted stock units. These RSUs were granted at no cash cost and increase his directly held stake to 293,406 Common Shares, aligning his compensation further with shareholder interests.
According to the grant terms, 25% of the RSUs vest on July 1, 2026, with additional 25% installments vesting annually over the following three years, as long as he remains in continuous service. On each vesting date, IBEX will automatically withhold a portion of the resulting shares to cover tax withholding obligations in a non-discretionary transaction.
Greenwald Taylor C reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd Chief Financial Officer Taylor C. Greenwald received a grant of 5,500 restricted stock units tied to IBEX common shares. Each RSU represents the right to receive one share. 25% vest on July 1, 2026, with additional 25% tranches vesting annually over the following three years, contingent on continued service. On each vesting date, IBEX will automatically withhold shares to cover tax obligations.
IBEX Ltd reported that Chief Operating Officer David Martin Afdahl acquired 4,400 common shares through a grant of restricted stock units. These RSUs carry no purchase price and represent a right to receive one share of common stock for each unit as they vest.
According to the award terms, 25% of the RSUs vest on July 1, 2026, with an additional 25% vesting each year for the next three years, as long as he remains in continuous service on each vesting date. Shares of common stock will be automatically withheld at each vesting to cover tax obligations. After this grant, he directly holds 157,302 common shares.
IBEX Ltd reported that Chief Sales/Marketing Officer Julie K. Casteel acquired 4,400 restricted stock units (RSUs) representing common shares. Each RSU converts into one common share as it vests. After this grant, she holds 121,194 common shares directly.
According to the award terms, 25% of the RSUs vest on July 1, 2026, with an additional 25% vesting on the same date in each of the following three years, provided she remains in continuous service. On each vesting date, shares of common stock will be automatically withheld to cover tax withholding obligations in a non‑discretionary transaction.
IBEX Ltd reported that Chief Sales and CS Officer Bruce Neil Dawson acquired 3,250 common shares through a grant of restricted stock units (RSUs) at a stated price of $0.00 per share. These RSUs convert into one common share each as they vest over time.
According to the award terms, 25% of the RSUs vest on July 1, 2026, with an additional 25% vesting annually over the following three years, so long as he remains continuously employed on each vesting date. After this grant, he directly holds 80,284 common shares. On each vesting date, a portion of shares will automatically be withheld by IBEX to cover tax withholding obligations in a non-discretionary transaction.
IBEX Ltd reported an equity award to its Chief Legal Officer, Christina Alice Trofimuk-O'Connor. She acquired 4,400 common shares in the form of restricted stock units (RSUs) at a price of $0.0000 per share, bringing her direct holdings to 35,735 common shares.
The RSUs vest over four years: 25% on July 1, 2026, with 25% vesting each year for the following three years, contingent on continued service. On each vesting date, IBEX will automatically withhold shares to cover tax obligations in a non-discretionary transaction.
Inson Paul Joseph reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd reported that Chief People Officer Paul Joseph Inson received a grant of 4,000 restricted stock units, each representing a right to one common share. The RSUs vest 25% on July 1, 2026, then 25% annually over the next three years, subject to continued service. After this award, he holds 31,469 common shares directly. On each vesting date, a portion of shares will be automatically withheld to cover tax obligations.
IBEX Ltd insider Michael Joseph Darwal, the Chief AI & Digital Officer, reported an "other" type transaction involving 925 Common Shares at a reference price of $28.39 per share. After this event, his directly held stake is 41,260 Common Shares.
According to the footnote, these shares were transferred to a third party under a legal agreement related to a divorce dated December 29, 2025. The filing states that this transfer does not represent a discretionary transaction by the reporting person, indicating it was driven by personal legal obligations rather than an active investment decision.
IBEX Ltd director and Chief Executive Officer Robert Thomas Dechant reported an open-market sale of 6,000 Common Shares. The shares were sold at a weighted average price of $28.4588 per share in multiple trades. After this transaction, he directly owns 275,406 Common Shares.
The sale price reflects a weighted average of individual trades executed between $28.25 and $29.02 per share, and detailed trade breakdowns are available upon request as noted in the filing footnote.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant reported selling a total of 12,000 Common Shares in two open-market transactions. He sold 6,000 shares on February 19, 2026 at a weighted average price of $29.7264 per share and another 6,000 shares on February 20, 2026 at a weighted average price of $29.3997 per share. After these sales, he continued to hold 281,406 Common Shares directly.
IBEX Ltd Chief Executive Officer and director Robert Thomas Dechant reported open-market sales of company common shares on two consecutive days. He sold 6,000 common shares on February 17 at a weighted average price of $29.6310 per share and another 6,000 shares on February 18 at a weighted average price of $29.9756 per share.
Both transactions were executed as multiple trades within stated price ranges, with detailed trade-level information available on request. Following these sales, Dechant directly owns 293,406 IBEX common shares.
IBEX Ltd’s Chief Sales/Marketing Officer, Julie K. Casteel, reported equity compensation activity in company common shares. On February 6, 2026, she acquired 97,126 restricted shares at $0 per share through a grant tied to a performance share award based on revenue and EBITDA targets.
On the same date, 8,649 shares were disposed of at $34.98 per share, representing shares withheld to cover taxes upon vesting. After these transactions, she directly held 116,794 common shares. One-third of the performance-based shares vested on February 6, 2026, with additional one-third tranches scheduled to vest on February 6, 2027 and February 6, 2028, subject to her continued service.
IBEX Ltd’s Chief Legal Officer, Christina Alice Trofimuk-O'Connor, reported equity compensation activity. On February 6, 2026, she acquired 19,557 common shares at $0 as a restricted stock award tied to an April 20, 2022 performance share grant based on revenue and EBITDA targets.
On the same date, 2,176 common shares were disposed of at $34.98 to cover taxes due at vesting. After these transactions, she directly held 31,335 IBEX common shares. One-third of the award vested on February 6, 2026, with additional thirds scheduled to vest on February 6, 2027 and February 6, 2028, subject to her continued service.
IBEX Ltd’s Chief Operating Officer, David Martin Afdahl, reported equity compensation activity. On February 6, 2026, he acquired 109,708 common shares at $0 as a restricted stock award tied to performance goals. On the same date, 13,917 shares were disposed of at $34.98 to cover taxes on the vesting. After these transactions, he directly owned 152,902 common shares. The award stems from an April 20, 2022 performance share grant that vests in three equal installments through 2028, contingent on continued service.
IBEX Ltd's Chief Financial Officer, Taylor C. Greenwald, reported equity compensation activity involving the company’s common shares. On February 6, 2026, the CFO acquired 20,000 common shares at $0 per share as a restricted stock award tied to a May 31, 2024 performance share grant based on revenue and EBITDA targets.
On the same date, 2,121 common shares were disposed of at $34.98 per share to cover tax withholding upon vesting. After these transactions, the CFO directly beneficially owned 54,361 common shares. One-third of the performance-based shares vested on February 6, 2026, with additional one‑third tranches scheduled to vest on February 6, 2027 and February 6, 2028, subject to continued service.
IBEX Ltd Chief AI & Digital Officer Michael Joseph Darwal reported several equity transactions. On February 11, 2026 he received a grant of 25,000 Restricted Stock Units, each representing one common share, vesting in four equal annual installments starting February 11, 2027, subject to continued service.
On February 6, 2026 he acquired 12,149 common shares at no cost upon vesting of an earlier performance share award tied to revenue and EBITDA targets, with additional thirds scheduled to vest on February 6, 2027 and February 6, 2028. That same day he sold 1,660 shares at $34.98 per share, described as shares withheld for tax purposes. After these transactions he directly owned 42,185 common shares.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant reported equity compensation transactions in IBEX common shares. On February 6, 2026, he acquired 124,582 common shares at $0 as a restricted stock award tied to an April 20, 2022 performance share grant based on revenue and EBITDA targets.
One-third of this award vested on February 6, 2026, with additional thirds scheduled to vest on February 6, 2027 and February 6, 2028, subject to his continued service. On the same date, 18,988 shares were disposed of at $34.98 to cover taxes, leaving Dechant with 305,406 common shares held directly.
IBEX Ltd’s Chief Sales and CS Officer, Bruce Neil Dawson, reported equity awards and related tax withholding in company stock. On February 6, 2026, he acquired 82,519 common shares at $0 per share as a restricted stock award tied to an April 20, 2022 performance share grant that met revenue and EBITDA targets.
These shares vest in three equal parts: one-third vested on February 6, 2026, with additional thirds scheduled for February 6, 2027 and February 6, 2028, contingent on his continued service. On the same date, 12,246 common shares were disposed of at $34.98 per share to satisfy tax withholding on the vesting. After these transactions, he directly owned 77,034 common shares.
IBEX Ltd’s Chief People Officer, Inson Paul Joseph, reported equity compensation activity. On February 6, 2026, he acquired 25,180 IBEX common shares at $0 as a restricted stock award tied to an April 20, 2022 performance share grant based on revenue and EBITDA targets.
One-third of the award vested on February 6, 2026, with additional one‑third tranches scheduled for February 6, 2027 and February 6, 2028, subject to continued service. On the same date, 2,627 shares were sold at $34.98 to cover taxes upon vesting, leaving him with 27,469 common shares held directly.
IBEX Ltd reported an amended insider transaction. The company’s Chief Executive Officer and Director filed a Form 4/A to record the exercise of a stock option for 45,027 common shares at $19 on 09/16/2025 (transaction code M). The filing shows 0 derivative securities remaining afterward, indicating this option position was fully exercised.
The amendment explains that the acquisition and sale of the shares underlying this option were previously reported on September 17, 2025, and the option exercise itself was inadvertently omitted and is now included. The option was fully vested and exercisable, with an expiration date of 08/07/2030. Ownership is listed as Direct.
IBEX Ltd reported an insider equity award. The company’s Chief Technology Officer filed a Form 4 for a grant of 15,000 Restricted Stock Units (RSUs) on November 11, 2025. Each RSU converts into one common share. The filing lists the acquisition at $0 and shows 15,000 shares beneficially owned directly after the transaction.
The RSUs vest over four years: 3,750 units on November 11, 2026, with an additional 3,750 units vesting annually thereafter, subject to continued service.